Sanofi US recalls

FDA enforcement reports naming Sanofi US as the recalling firm.

Recall reports: 1
Class I (serious): 0
Most recent report: Aug 14, 2013

Severity

Aug 14, 2013Rifadin, Rifampin capsules, 150 mg, packaged in 30-count bottle, Rx only, MfdDrug · Sanofi USSubpotent drug: low fill volume in some of the capsulesClass II